Daily Eye Drops May Replace Reading Glasses
- This report summarizes findings from a retrospective study presented at the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) regarding a novel eye drop...
- * Presbyopia: A common age-related condition affecting near vision, often requiring reading glasses.
- * Pilocarpine: Constricts pupils and contracts the ciliary muscle (improves accommodation).
Presbyopia & novel Eye Drop Treatment: A Summary
– drjenniferchen
This report summarizes findings from a retrospective study presented at the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) regarding a novel eye drop treatment for presbyopia (age-related difficulty focusing on near objects).
Key facts:
* Presbyopia: A common age-related condition affecting near vision, often requiring reading glasses.
* Study Type: Retrospective study of 766 patients.
* Presentation Date: September 14th at the ESCRS Congress.
* Focus: Providing a non-invasive choice to reading glasses or surgery for presbyopia sufferers.
The Eye Drops:
The eye drops combine two active ingredients:
* Pilocarpine: Constricts pupils and contracts the ciliary muscle (improves accommodation). Concentrations tested were 1%,2%,and 3%.
* Diclofenac: A non-steroidal anti-inflammatory drug (NSAID) to reduce discomfort caused by pilocarpine.
Study Demographics:
* Total Patients: 766
* Women: 373
* Men: 393
* Average Age: 55 years
Results – Improvement in Near Vision (Jaeger Chart):
The following table summarizes the percentage of patients achieving specific improvements in Jaeger chart lines read without reading glasses:
| Pilocarpine Concentration | ≥ 2 Lines Improved | ≥ 3 lines Improved |
|---|---|---|
| 1% | 99% | Not Reported |
| 2% | Not Reported | 69% |
| 3% | Not Reported | 84% |
* Average Improvement: 3.45 Jaeger lines one hour after the first dose.
* Sustained Improvement: Improvement lasted up to two years (median duration 434 days).
* Functional Near Vision: approximately 83% of all patients maintained good functional near vision at 12 months.
Adverse Effects:
* Overall: Mild. No patients discontinued treatment.
* Common:
* Temporary dim vision (32%)
* Irritation upon instillation (3.7%)
* Headache (3.8%)
* Potential (from pilocarpine): Eye redness, watery eyes, blurred vision, sensitivity to light, floaters, retinal detachment (rare).
* Notably: No meaningful adverse events like increased intraocular pressure or retinal detachment were observed in this study.
Conclusion:
The study suggests that these eye drops offer a promising, non-invasive, and effective treatment option for presbyopia, wiht rapid and sustained improvements in near vision and a favorable safety profile.